Phase 2 Atopic Dermatitis (AD) Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Bluefin Biomedicine, Inc.225 enrolled55 locationsNCT07105488
Recruiting
Phase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Enveda Therapeutics60 enrolled17 locationsNCT07298395
Recruiting
Phase 2
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
Atopic Dermatitis (AD)
Keymed Biosciences Co.Ltd246 enrolled1 locationNCT07230483
Recruiting
Phase 2Phase 3
Herbal Ointment in Treating Atopic Dermatitis Topically
Atopic DermatitisAtopic Dermatitis (AD)
En Chu Kong Hospital66 enrolled1 locationNCT06850311
Recruiting
Phase 2
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Atopic Dermatitis (AD)
CAGE Bio Inc.180 enrolled16 locationsNCT06810050